Tesamorelin

Tesamorelin is a synthetic growth hormone releasing hormone (GHRH) designed to stimulate the production and secretion of growth hormone (GH) from the pituitary gland by mimicking the action of the natural hormone. Its primary medical application is in the treatment of HIV-associated lipodystrophy, a condition characterized by abnormal fat redistribution in individuals living with HIV. By promoting the release of growth hormone, Tesamorelin can help reduce visceral fat accumulation, particularly in the abdominal region, leading to improvements in body composition. Additionally, Tesamorelin’s potential anti-aging effects, including improved muscle mass and skin quality, have gained interest in the field of age-related health.

• Stimulate Growth Hormone Release
• Improve Body Composition by Reducing Visceral Fat and Increasing Muscle Mass
• Increase Bone Mineral Density
• Enhance Cardiovascular Health

Tesamorelin is commonly used with Ipamorelin, BPC-157 and TB-500.